Linge Helena M, Collin Mattias, Nordenfelt Pontus, Mörgelin Matthias, Malmsten Martin, Egesten Arne
Divisions of Infection, Department of Clinical Sciences Lund, Lund University, SE-221 84 Lund, Sweden.
Antimicrob Agents Chemother. 2008 Jul;52(7):2599-607. doi: 10.1128/AAC.00028-08. Epub 2008 Apr 28.
Granulocyte chemotactic protein 2 (GCP-2)/CXCL6 is a CXC chemokine expressed by macrophages and epithelial and mesenchymal cells during inflammation. Through binding and activation of its receptors (CXCR1 and CXCR2), it exerts neutrophil-activating and angiogenic activities. Here we show that GCP-2/CXCL6 itself is antibacterial. Antibacterial activity against gram-positive and gram-negative pathogenic bacteria of relevance to mucosal infections was seen at submicromolar concentrations (minimal bactericidal concentration at which 50% of strains tested were killed, 0.063 +/- 0.01 to 0.37 +/- 0.03 muM). In killed bacteria, GCP-2/CXCL6 associated with bacterial surfaces, which showed membrane disruption and leakage. A structural prediction indicated the presence of three antiparallel NH(2)-terminal beta-sheets and a short amphipathic COOH-terminal alpha-helix; the latter feature is typical of antimicrobial peptides. However, when the synthetic derivatives corresponding to the NH(2)-terminal (50 amino acids) and COOH-terminal (19 amino acids, corresponding to the putative alpha-helix) regions were compared, higher antibacterial activity was observed for the NH(2)-terminus-derived peptide, indicating that the holopeptide is necessary for full antibacterial activity. An artificial model of bacterial membranes confirmed these findings. The helical content of GCP-2/CXCL6 in the presence or absence of lipopolysaccharide or negatively charged membranes was studied by circular dichroism. As with many antibacterial peptides, membrane disruption by GCP-2/CXCL6 was dose-dependently reduced in the presence of NaCl, which, we here demonstrate, inhibited the binding of the peptide to the bacterial surface. Compared with CXC chemokines ENA-78/CXCL5 and NAP-2/CXCL7, GCP-2/CXCL6 showed a 90-fold-higher antibacterial activity. Taken together, GCP/CXCL6, in addition to its chemotactic and angiogenic properties, is likely to contribute to direct antibacterial activity during localized infection.
粒细胞趋化蛋白2(GCP-2)/CXCL6是一种CXC趋化因子,在炎症过程中由巨噬细胞、上皮细胞和间充质细胞表达。通过与其受体(CXCR1和CXCR2)结合并激活,它发挥中性粒细胞激活和血管生成活性。在此我们表明GCP-2/CXCL6本身具有抗菌作用。在亚微摩尔浓度下可观察到其对与黏膜感染相关的革兰氏阳性和革兰氏阴性病原菌的抗菌活性(使50%受试菌株被杀灭的最低杀菌浓度,0.063±0.01至0.37±0.03μM)。在杀灭的细菌中,GCP-2/CXCL6与细菌表面结合,表现出膜破坏和渗漏。结构预测表明存在三个反平行的氨基末端β折叠和一个短的两亲性羧基末端α螺旋;后一特征是抗菌肽的典型特征。然而,当比较对应于氨基末端(50个氨基酸)和羧基末端(19个氨基酸,对应于假定的α螺旋)区域的合成衍生物时,观察到氨基末端衍生肽具有更高的抗菌活性,表明完整肽对于充分的抗菌活性是必需的。细菌膜的人工模型证实了这些发现。通过圆二色性研究了在存在或不存在脂多糖或带负电荷膜的情况下GCP-2/CXCL6的螺旋含量。与许多抗菌肽一样,在存在氯化钠的情况下,GCP-2/CXCL6引起的膜破坏呈剂量依赖性降低,我们在此证明,氯化钠抑制了该肽与细菌表面的结合。与CXC趋化因子ENA-78/CXCL5和NAP-2/CXCL7相比,GCP-2/CXCL6表现出高90倍的抗菌活性。综上所述,GCP/CXCL6除了其趋化和血管生成特性外,可能在局部感染期间有助于直接抗菌活性。